By comparing the performance of wild-type and PGGT1B knockout mice in the psoriasis model, we found that the lack of PGGT1B in bone marrow significantly aggravated the psoriasis-like lesions induced by imiquimod in mice. This evidence concerns the gene PGGT1B and psoriasis.